Jason McCarthy
Stock Analyst at Maxim Group
(1.19)
# 2,632
Out of 4,412 analysts
125
Total ratings
26.36%
Success rate
-11.07%
Average return
Main Sectors:
76 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIPO Lipella Pharmaceuticals | Initiates: Buy | $2 | $0.71 | +181.29% | 1 | Apr 9, 2024 | |
| RZLT Rezolute | Initiates: Buy | $8 | $2.66 | +200.75% | 1 | Apr 9, 2024 | |
| ATAI Atai Life Sciences | Upgrades: Buy | $6 | $1.93 | +210.88% | 1 | Apr 3, 2024 | |
| MBRX Moleculin Biotech | Maintains: Buy | $45 → $20 | $4.63 | +331.97% | 1 | Mar 26, 2024 | |
| ATNM Actinium Pharmaceuticals | Maintains: Buy | $20 → $30 | $6.87 | +336.68% | 1 | Mar 19, 2024 | |
| BLTE Belite Bio | Initiates: Buy | $60 | $39.75 | +50.94% | 1 | Dec 14, 2023 | |
| ATXI Avenue Therapeutics | Initiates: Buy | $0.75 | $6.20 | -87.90% | 1 | Dec 11, 2023 | |
| RNXT RenovoRx | Downgrades: Hold | n/a | $1.24 | - | 2 | Nov 15, 2023 | |
| BNGO Bionano Genomics | Downgrades: Hold | n/a | $0.79 | - | 1 | Nov 13, 2023 | |
| CHRS Coherus BioSciences | Downgrades: Hold | n/a | $2.04 | - | 1 | Nov 8, 2023 | |
| BNOX Bionomics | Maintains: Buy | $7 → $10 | $1.00 | +900.00% | 2 | Sep 28, 2023 | |
| BCLI Brainstorm Cell Therapeutics | Downgrades: Hold | n/a | $0.53 | - | 3 | Sep 28, 2023 | |
| CYTH Cyclo Therapeutics | Upgrades: Buy | $4 | $1.26 | +217.46% | 2 | Sep 27, 2023 | |
| NLSP NLS Pharmaceutics AG | Downgrades: Hold | n/a | $0.14 | - | 4 | Sep 14, 2023 | |
| GANX Gain Therapeutics | Initiates: Buy | $10 | $3.03 | +230.03% | 1 | Sep 12, 2023 | |
| GNLX Genelux | Initiates: Buy | $40 | $3.40 | +1,076.47% | 1 | Sep 12, 2023 | |
| CNTX Context Therapeutics | Initiates: Buy | $4 | $1.41 | +183.67% | 1 | Sep 11, 2023 | |
| VTGN VistaGen Therapeutics | Maintains: Buy | $30 | $4.75 | +531.58% | 3 | Sep 5, 2023 | |
| MESO Mesoblast | Downgrades: Hold | n/a | $6.24 | - | 3 | Aug 7, 2023 | |
| GLMD Galmed Pharmaceuticals | Upgrades: Buy | $4 | $0.39 | +921.45% | 4 | Jul 24, 2023 | |
| KTRA Kintara Therapeutics | Upgrades: Buy | $14 | $0.15 | +9,308.60% | 2 | Jul 14, 2023 | |
| IMMP Immutep | Maintains: Buy | $8 → $10 | $2.65 | +277.36% | 2 | May 18, 2023 | |
| TCON TRACON Pharmaceuticals | Maintains: Buy | $160 → $60 | $1.81 | +3,214.92% | 1 | May 11, 2023 | |
| PSTV Plus Therapeutics | Maintains: Buy | $30 → $12 | $1.69 | +610.06% | 2 | May 3, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Maintains: Buy | $10 → $18 | $2.99 | +502.01% | 3 | May 3, 2023 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $325 → $400 | $397.48 | +0.63% | 3 | May 3, 2023 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $0.66 | - | 2 | Mar 29, 2023 | |
| PBLA Panbela Therapeutics | Upgrades: Buy | $900 | $0.41 | +219,412.20% | 3 | Mar 20, 2023 | |
| ZVRA Zevra Therapeutics | Initiates: Buy | $12 | $4.52 | +165.49% | 1 | Mar 17, 2023 | |
| APRE Aprea Therapeutics | Initiates: Buy | $16 | $5.20 | +207.69% | 1 | Mar 10, 2023 | |
| UNCY Unicycive Therapeutics | Maintains: Buy | $3 → $6 | $1.03 | +482.52% | 2 | Mar 9, 2023 | |
| SNPX Synaptogenix | Downgrades: Hold | n/a | $4.53 | - | 2 | Dec 19, 2022 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $21 → $8 | $4.61 | +73.54% | 1 | Nov 16, 2022 | |
| ABVC ABVC BioPharma | Downgrades: Hold | n/a | $1.42 | - | 1 | Nov 16, 2022 | |
| INO Inovio Pharmaceuticals | Downgrades: Hold | n/a | $10.57 | - | 4 | Nov 9, 2022 | |
| GILD Gilead Sciences | Maintains: Buy | $84 → $92 | $65.42 | +40.63% | 3 | Oct 31, 2022 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $3 | $1.09 | +175.23% | 1 | Oct 6, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $8 → $5 | $0.91 | +447.23% | 1 | Aug 23, 2022 | |
| ADIL Adial Pharmaceuticals | Downgrades: Hold | n/a | $1.61 | - | 1 | Aug 17, 2022 | |
| ARDS Aridis Pharmaceuticals | Downgrades: Hold | n/a | $0.07 | - | 1 | Aug 16, 2022 | |
| KZIA Kazia Therapeutics | Downgrades: Hold | n/a | $0.37 | - | 1 | Aug 2, 2022 | |
| FEMY Femasys | Initiates: Buy | $5 | $1.27 | +293.70% | 1 | Jun 17, 2022 | |
| TTNP Titan Pharmaceuticals | Downgrades: Hold | n/a | $7.09 | - | 4 | May 26, 2022 | |
| GOVX GeoVax Labs | Reiterates: Buy | $90 | $1.42 | +6,238.03% | 2 | May 23, 2022 | |
| INVO INVO Bioscience | Initiates: Buy | $140 | $0.98 | +14,185.71% | 1 | Jan 19, 2022 | |
| KPRX Kiora Pharmaceuticals | Initiates: Buy | $100 | $0.47 | +21,176.60% | 1 | Jan 19, 2022 | |
| ACXP Acurx Pharmaceuticals | Initiates: Buy | n/a | $2.07 | - | 1 | Nov 29, 2021 | |
| CYBN Cybin | Downgrades: Hold | n/a | $0.35 | - | 1 | Nov 19, 2021 | |
| PTIX Protagenic Therapeutics | Initiates: Buy | n/a | $1.39 | - | 1 | Oct 29, 2021 | |
| INDP Indaptus Therapeutics | Upgrades: Buy | n/a | $2.44 | - | 1 | Oct 19, 2021 | |
| OMER Omeros | Downgrades: Hold | n/a | $3.15 | - | 4 | Oct 4, 2021 | |
| ATNF 180 Life Sciences | Initiates: Buy | $4,180 | $1.80 | +232,122.22% | 1 | Sep 15, 2021 | |
| CMPS COMPASS Pathways | Initiates: Buy | n/a | $7.94 | - | 1 | Jun 28, 2021 | |
| ENVB Enveric Biosciences | Initiates: Buy | n/a | $0.90 | - | 1 | Jun 28, 2021 | |
| MNMD Mind Medicine (MindMed) | Initiates: Buy | n/a | $8.52 | - | 1 | Jun 28, 2021 | |
| CLNN Clene | Initiates: Buy | n/a | $0.34 | - | 1 | May 20, 2021 | |
| CWBR CohBar | Initiates: Buy | n/a | $0.80 | - | 1 | Apr 23, 2021 | |
| FENC Fennec Pharmaceuticals | Initiates: Buy | n/a | $9.21 | - | 1 | Apr 19, 2021 | |
| CODX Co-Diagnostics | Downgrades: Hold | n/a | $1.11 | - | 2 | Mar 29, 2021 | |
| MNOV MediciNova | Initiates: Buy | n/a | $1.31 | - | 1 | Mar 10, 2021 | |
| SAVA Cassava Sciences | Maintains: Buy | n/a | $22.34 | - | 2 | Feb 16, 2021 | |
| ARTL Artelo Biosciences | Upgrades: Buy | n/a | $1.34 | - | 2 | Jan 7, 2021 | |
| GLPG Galapagos NV | Initiates: Buy | n/a | $28.76 | - | 1 | Nov 19, 2020 | |
| TFFP TFF Pharmaceuticals | Initiates: Buy | $300 | $2.92 | +10,168.70% | 1 | Jul 8, 2020 | |
| DMAC DiaMedica Therapeutics | Initiates: Buy | n/a | $2.57 | - | 1 | Jul 8, 2020 | |
| CLRB Cellectar Biosciences | Initiates: Buy | n/a | $3.03 | - | 1 | Jun 23, 2020 | |
| APTO Aptose Biosciences | Initiates: Buy | n/a | $1.22 | - | 1 | Feb 20, 2020 | |
| ATOS Atossa Therapeutics | Upgrades: Buy | n/a | $1.53 | - | 1 | Dec 18, 2019 | |
| MTNB Matinas BioPharma Holdings | Maintains: Buy | n/a | $0.18 | - | 3 | Nov 13, 2018 | |
| SCYX SCYNEXIS | Maintains: Buy | n/a | $1.54 | - | 1 | Oct 16, 2018 | |
| ADMA ADMA Biologics | Maintains: Buy | n/a | $6.55 | - | 2 | Jul 27, 2018 | |
| SLS SELLAS Life Sciences Group | Maintains: Buy | n/a | $1.46 | - | 2 | Jul 20, 2018 | |
| BYSI BeyondSpring | Maintains: Buy | n/a | $2.13 | - | 1 | Jun 22, 2018 | |
| VKTX Viking Therapeutics | Maintains: Buy | n/a | $74.31 | - | 1 | Jun 1, 2018 | |
| BLFS BioLife Solutions | Maintains: Buy | n/a | $17.53 | - | 2 | May 11, 2018 | |
| BLUE bluebird bio | Downgrades: Hold | n/a | $0.92 | - | 3 | Dec 13, 2017 |
Lipella Pharmaceuticals
Apr 9, 2024
Initiates: Buy
Price Target: $2
Current: $0.71
Upside: +181.29%
Rezolute
Apr 9, 2024
Initiates: Buy
Price Target: $8
Current: $2.66
Upside: +200.75%
Atai Life Sciences
Apr 3, 2024
Upgrades: Buy
Price Target: $6
Current: $1.93
Upside: +210.88%
Moleculin Biotech
Mar 26, 2024
Maintains: Buy
Price Target: $45 → $20
Current: $4.63
Upside: +331.97%
Actinium Pharmaceuticals
Mar 19, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $6.87
Upside: +336.68%
Belite Bio
Dec 14, 2023
Initiates: Buy
Price Target: $60
Current: $39.75
Upside: +50.94%
Avenue Therapeutics
Dec 11, 2023
Initiates: Buy
Price Target: $0.75
Current: $6.20
Upside: -87.90%
RenovoRx
Nov 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.24
Upside: -
Bionano Genomics
Nov 13, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.79
Upside: -
Coherus BioSciences
Nov 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.04
Upside: -
Bionomics
Sep 28, 2023
Maintains: Buy
Price Target: $7 → $10
Current: $1.00
Upside: +900.00%
Brainstorm Cell Therapeutics
Sep 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.53
Upside: -
Cyclo Therapeutics
Sep 27, 2023
Upgrades: Buy
Price Target: $4
Current: $1.26
Upside: +217.46%
NLS Pharmaceutics AG
Sep 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.14
Upside: -
Gain Therapeutics
Sep 12, 2023
Initiates: Buy
Price Target: $10
Current: $3.03
Upside: +230.03%
Genelux
Sep 12, 2023
Initiates: Buy
Price Target: $40
Current: $3.40
Upside: +1,076.47%
Context Therapeutics
Sep 11, 2023
Initiates: Buy
Price Target: $4
Current: $1.41
Upside: +183.67%
VistaGen Therapeutics
Sep 5, 2023
Maintains: Buy
Price Target: $30
Current: $4.75
Upside: +531.58%
Mesoblast
Aug 7, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.24
Upside: -
Galmed Pharmaceuticals
Jul 24, 2023
Upgrades: Buy
Price Target: $4
Current: $0.39
Upside: +921.45%
Kintara Therapeutics
Jul 14, 2023
Upgrades: Buy
Price Target: $14
Current: $0.15
Upside: +9,308.60%
Immutep
May 18, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $2.65
Upside: +277.36%
TRACON Pharmaceuticals
May 11, 2023
Maintains: Buy
Price Target: $160 → $60
Current: $1.81
Upside: +3,214.92%
Plus Therapeutics
May 3, 2023
Maintains: Buy
Price Target: $30 → $12
Current: $1.69
Upside: +610.06%
Reviva Pharmaceuticals Holdings
May 3, 2023
Maintains: Buy
Price Target: $10 → $18
Current: $2.99
Upside: +502.01%
Vertex Pharmaceuticals
May 3, 2023
Maintains: Buy
Price Target: $325 → $400
Current: $397.48
Upside: +0.63%
Monopar Therapeutics
Mar 29, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.66
Upside: -
Panbela Therapeutics
Mar 20, 2023
Upgrades: Buy
Price Target: $900
Current: $0.41
Upside: +219,412.20%
Zevra Therapeutics
Mar 17, 2023
Initiates: Buy
Price Target: $12
Current: $4.52
Upside: +165.49%
Aprea Therapeutics
Mar 10, 2023
Initiates: Buy
Price Target: $16
Current: $5.20
Upside: +207.69%
Unicycive Therapeutics
Mar 9, 2023
Maintains: Buy
Price Target: $3 → $6
Current: $1.03
Upside: +482.52%
Synaptogenix
Dec 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $4.53
Upside: -
Achieve Life Sciences
Nov 16, 2022
Maintains: Buy
Price Target: $21 → $8
Current: $4.61
Upside: +73.54%
ABVC BioPharma
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.42
Upside: -
Inovio Pharmaceuticals
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $10.57
Upside: -
Gilead Sciences
Oct 31, 2022
Maintains: Buy
Price Target: $84 → $92
Current: $65.42
Upside: +40.63%
Oncolytics Biotech
Oct 6, 2022
Initiates: Buy
Price Target: $3
Current: $1.09
Upside: +175.23%
VolitionRx
Aug 23, 2022
Maintains: Buy
Price Target: $8 → $5
Current: $0.91
Upside: +447.23%
Adial Pharmaceuticals
Aug 17, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.61
Upside: -
Aridis Pharmaceuticals
Aug 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.07
Upside: -
Kazia Therapeutics
Aug 2, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.37
Upside: -
Femasys
Jun 17, 2022
Initiates: Buy
Price Target: $5
Current: $1.27
Upside: +293.70%
Titan Pharmaceuticals
May 26, 2022
Downgrades: Hold
Price Target: n/a
Current: $7.09
Upside: -
GeoVax Labs
May 23, 2022
Reiterates: Buy
Price Target: $90
Current: $1.42
Upside: +6,238.03%
INVO Bioscience
Jan 19, 2022
Initiates: Buy
Price Target: $140
Current: $0.98
Upside: +14,185.71%
Kiora Pharmaceuticals
Jan 19, 2022
Initiates: Buy
Price Target: $100
Current: $0.47
Upside: +21,176.60%
Acurx Pharmaceuticals
Nov 29, 2021
Initiates: Buy
Price Target: n/a
Current: $2.07
Upside: -
Cybin
Nov 19, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.35
Upside: -
Protagenic Therapeutics
Oct 29, 2021
Initiates: Buy
Price Target: n/a
Current: $1.39
Upside: -
Indaptus Therapeutics
Oct 19, 2021
Upgrades: Buy
Price Target: n/a
Current: $2.44
Upside: -
Omeros
Oct 4, 2021
Downgrades: Hold
Price Target: n/a
Current: $3.15
Upside: -
180 Life Sciences
Sep 15, 2021
Initiates: Buy
Price Target: $4,180
Current: $1.80
Upside: +232,122.22%
COMPASS Pathways
Jun 28, 2021
Initiates: Buy
Price Target: n/a
Current: $7.94
Upside: -
Enveric Biosciences
Jun 28, 2021
Initiates: Buy
Price Target: n/a
Current: $0.90
Upside: -
Mind Medicine (MindMed)
Jun 28, 2021
Initiates: Buy
Price Target: n/a
Current: $8.52
Upside: -
Clene
May 20, 2021
Initiates: Buy
Price Target: n/a
Current: $0.34
Upside: -
CohBar
Apr 23, 2021
Initiates: Buy
Price Target: n/a
Current: $0.80
Upside: -
Fennec Pharmaceuticals
Apr 19, 2021
Initiates: Buy
Price Target: n/a
Current: $9.21
Upside: -
Co-Diagnostics
Mar 29, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.11
Upside: -
MediciNova
Mar 10, 2021
Initiates: Buy
Price Target: n/a
Current: $1.31
Upside: -
Cassava Sciences
Feb 16, 2021
Maintains: Buy
Price Target: n/a
Current: $22.34
Upside: -
Artelo Biosciences
Jan 7, 2021
Upgrades: Buy
Price Target: n/a
Current: $1.34
Upside: -
Galapagos NV
Nov 19, 2020
Initiates: Buy
Price Target: n/a
Current: $28.76
Upside: -
TFF Pharmaceuticals
Jul 8, 2020
Initiates: Buy
Price Target: $300
Current: $2.92
Upside: +10,168.70%
DiaMedica Therapeutics
Jul 8, 2020
Initiates: Buy
Price Target: n/a
Current: $2.57
Upside: -
Cellectar Biosciences
Jun 23, 2020
Initiates: Buy
Price Target: n/a
Current: $3.03
Upside: -
Aptose Biosciences
Feb 20, 2020
Initiates: Buy
Price Target: n/a
Current: $1.22
Upside: -
Atossa Therapeutics
Dec 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $1.53
Upside: -
Matinas BioPharma Holdings
Nov 13, 2018
Maintains: Buy
Price Target: n/a
Current: $0.18
Upside: -
SCYNEXIS
Oct 16, 2018
Maintains: Buy
Price Target: n/a
Current: $1.54
Upside: -
ADMA Biologics
Jul 27, 2018
Maintains: Buy
Price Target: n/a
Current: $6.55
Upside: -
SELLAS Life Sciences Group
Jul 20, 2018
Maintains: Buy
Price Target: n/a
Current: $1.46
Upside: -
BeyondSpring
Jun 22, 2018
Maintains: Buy
Price Target: n/a
Current: $2.13
Upside: -
Viking Therapeutics
Jun 1, 2018
Maintains: Buy
Price Target: n/a
Current: $74.31
Upside: -
BioLife Solutions
May 11, 2018
Maintains: Buy
Price Target: n/a
Current: $17.53
Upside: -
bluebird bio
Dec 13, 2017
Downgrades: Hold
Price Target: n/a
Current: $0.92
Upside: -